Authors
Andrew H Ko, Mokenge P Malafa, Todd Aguilera, Olca Basturk, Al B Benson, Dana B Cardin, E Gabriela Chiorean, Jared A Christensen, Vincent Chung, Brian Czito, Marco Del Chiaro, Mary Dillhoff, Timothy R Donahue, Christos Fountzilas, Jeffrey Hardacre, Kelsey Klute, John W Kunstman, Kian-Huat Lim, Noelle LoConte, Andrew M Lowy, Ashiq Masood, Cassadie Moravek, Eric K Nakakura, Amol K Narang, Lorenzo Nardo, Jorge Obando, Patricio M Polanco, George Poultsides, Sushanth Reddy, Marsha Reyngold, Courtney Scaife, Ardaman Shergill, Harshabad Singh, Mark J Truty, Charles Vollmer, David Weinberg, Robert A Wolff, Brian M Wolpin, Beth McCullough, Sydney L Roth, Swathi Ramakrishnan
Published in
Journal of the National Comprehensive Cancer Network : JNCCN. Volume 24. Issue 10.
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma provide multidisciplinary diagnostic workup, staging, and treatment recommendations for resectable, borderline resectable, unresectable, locally advanced, and metastatic disease. This article summarizes the studies and Panel discussion that serve as the rationale for comprehensive care recommendations included in the NCCN Guidelines for Pancreatic Adenocarcinoma.
PMID:
42869082
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 24
- Comments 0